-
1
-
-
84872307406
-
New targets and approaches in osteosarcoma
-
Gill J, Ahluwalia MK, Geller D, Gorlick R, (2013) New targets and approaches in osteosarcoma. Pharmacol Ther 137: 89-99.
-
(2013)
Pharmacol Ther
, vol.137
, pp. 89-99
-
-
Gill, J.1
Ahluwalia, M.K.2
Geller, D.3
Gorlick, R.4
-
2
-
-
79952165556
-
Palliative therapy for osteosarcoma
-
Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, et al. (2011) Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 11: 217-227.
-
(2011)
Expert Rev Anticancer Ther
, vol.11
, pp. 217-227
-
-
Errani, C.1
Longhi, A.2
Rossi, G.3
Rimondi, E.4
Biazzo, A.5
-
3
-
-
31744450019
-
Management of osteosarcoma pulmonary metastases
-
Harting MT, Blakely ML, (2006) Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg 15: 25-29.
-
(2006)
Semin Pediatr Surg
, vol.15
, pp. 25-29
-
-
Harting, M.T.1
Blakely, M.L.2
-
4
-
-
77951956479
-
Osteosarcoma lung metastases detection and principles of multimodal therapy
-
Carrle D, Bielack S, (2009) Osteosarcoma lung metastases detection and principles of multimodal therapy. Cancer Treat Res 152: 165-184.
-
(2009)
Cancer Treat Res
, vol.152
, pp. 165-184
-
-
Carrle, D.1
Bielack, S.2
-
5
-
-
77954987492
-
Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma
-
Strauss SJ, Ng T, Mendoza-Naranjo A, Whelan J, Sorensen PH, (2010) Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma. Oncologist 15: 627-635.
-
(2010)
Oncologist
, vol.15
, pp. 627-635
-
-
Strauss, S.J.1
Ng, T.2
Mendoza-Naranjo, A.3
Whelan, J.4
Sorensen, P.H.5
-
6
-
-
77953652460
-
Osteosarcoma: the COSS experience
-
Bielack S, Jurgens H, Jundt G, Kevric M, Kuhne T, et al. (2009) Osteosarcoma: the COSS experience. Cancer Treat Res 152: 289-308.
-
(2009)
Cancer Treat Res
, vol.152
, pp. 289-308
-
-
Bielack, S.1
Jurgens, H.2
Jundt, G.3
Kevric, M.4
Kuhne, T.5
-
7
-
-
33645828043
-
Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma
-
Nardin A, Lefebvre ML, Labroquere K, Faure O, Abastado JP, (2006) Liposomal muramyl tripeptide phosphatidylethanolamine: Targeting and activating macrophages for adjuvant treatment of osteosarcoma. Curr Cancer Drug Targets 6: 123-133.
-
(2006)
Curr Cancer Drug Targets
, vol.6
, pp. 123-133
-
-
Nardin, A.1
Lefebvre, M.L.2
Labroquere, K.3
Faure, O.4
Abastado, J.P.5
-
8
-
-
77953673602
-
Is there a role for immunotherapy in osteosarcoma?
-
Loeb DM, (2009) Is there a role for immunotherapy in osteosarcoma? Cancer Treat Res 152: 447-457.
-
(2009)
Cancer Treat Res
, vol.152
, pp. 447-457
-
-
Loeb, D.M.1
-
10
-
-
84860759062
-
Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma
-
Himoudi N, Wallace R, Parsley KL, Gilmour K, Barrie AU, et al. (2012) Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma. Clin Transl Oncol 14: 271-279.
-
(2012)
Clin Transl Oncol
, vol.14
, pp. 271-279
-
-
Himoudi, N.1
Wallace, R.2
Parsley, K.L.3
Gilmour, K.4
Barrie, A.U.5
-
11
-
-
0032736029
-
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
-
Dong H, Zhu G, Tamada K, Chen L, (1999) B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-1369.
-
(1999)
Nat Med
, vol.5
, pp. 1365-1369
-
-
Dong, H.1
Zhu, G.2
Tamada, K.3
Chen, L.4
-
12
-
-
0034667688
-
Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS
-
Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, et al. (2000) Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813.
-
(2000)
Blood
, vol.96
, pp. 2808-2813
-
-
Wang, S.1
Zhu, G.2
Chapoval, A.I.3
Dong, H.4
Tamada, K.5
-
13
-
-
5844252552
-
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production
-
Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, et al. (2001) B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol 2: 269-274.
-
(2001)
Nat Immunol
, vol.2
, pp. 269-274
-
-
Chapoval, A.I.1
Ni, J.2
Lau, J.S.3
Wilcox, R.A.4
Flies, D.B.5
-
14
-
-
0038094524
-
B7-H4, a molecule of the B7 family, negatively regulates T cell immunity
-
Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, et al. (2003) B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18: 849-861.
-
(2003)
Immunity
, vol.18
, pp. 849-861
-
-
Sica, G.L.1
Choi, I.H.2
Zhu, G.3
Tamada, K.4
Wang, S.D.5
-
15
-
-
0035794314
-
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
-
Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, et al. (2001) B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-846.
-
(2001)
J Exp Med
, vol.193
, pp. 839-846
-
-
Tseng, S.Y.1
Otsuji, M.2
Gorski, K.3
Huang, X.4
Slansky, J.E.5
-
16
-
-
67650507057
-
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
-
Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, et al. (2009) The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 206: 1495-1503.
-
(2009)
J Exp Med
, vol.206
, pp. 1495-1503
-
-
Brandt, C.S.1
Baratin, M.2
Yi, E.C.3
Kennedy, J.4
Gao, Z.5
-
17
-
-
84875238628
-
Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung
-
Boland JM, Kwon ED, Harrington SM, Wampfler JA, Tang H, et al. (2012) Tumor B7-H1 and B7-H3 Expression in Squamous Cell Carcinoma of the Lung. Clin Lung Cancer.
-
(2012)
Clin Lung Cancer
-
-
Boland, J.M.1
Kwon, E.D.2
Harrington, S.M.3
Wampfler, J.A.4
Tang, H.5
-
18
-
-
79954617324
-
B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells
-
Arigami T, Uenosono Y, Hirata M, Yanagita S, Ishigami S, et al. (2011) B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells. Cancer Sci 102: 1019-1024.
-
(2011)
Cancer Sci
, vol.102
, pp. 1019-1024
-
-
Arigami, T.1
Uenosono, Y.2
Hirata, M.3
Yanagita, S.4
Ishigami, S.5
-
19
-
-
78650151049
-
B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis
-
Arigami T, Narita N, Mizuno R, Nguyen L, Ye X, et al. (2010) B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg 252: 1044-1051.
-
(2010)
Ann Surg
, vol.252
, pp. 1044-1051
-
-
Arigami, T.1
Narita, N.2
Mizuno, R.3
Nguyen, L.4
Ye, X.5
-
20
-
-
37649013179
-
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
-
Zang X, Thompson RH, Al-Ahmadie HA, Serio AM, Reuter VE, et al. (2007) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A 104: 19458-19463.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 19458-19463
-
-
Zang, X.1
Thompson, R.H.2
Al-Ahmadie, H.A.3
Serio, A.M.4
Reuter, V.E.5
-
21
-
-
84873699578
-
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
-
Wang L, Kang F, Li J, Zhang J, Shan B, (2013) Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. Cancer Cell Int 13: 14.
-
(2013)
Cancer Cell Int
, vol.13
, pp. 14
-
-
Wang, L.1
Kang, F.2
Li, J.3
Zhang, J.4
Shan, B.5
-
22
-
-
84859099360
-
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
-
Tekle C, Nygren MK, Chen YW, Dybsjord I, Nesland JM, et al. (2012) B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer 130: 2282-2290.
-
(2012)
Int J Cancer
, vol.130
, pp. 2282-2290
-
-
Tekle, C.1
Nygren, M.K.2
Chen, Y.W.3
Dybsjord, I.4
Nesland, J.M.5
-
23
-
-
83055172736
-
Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis
-
Brunner A, Hinterholzer S, Riss P, Heinze G, Brustmann H, (2012) Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis. Gynecol Oncol 124: 105-111.
-
(2012)
Gynecol Oncol
, vol.124
, pp. 105-111
-
-
Brunner, A.1
Hinterholzer, S.2
Riss, P.3
Heinze, G.4
Brustmann, H.5
-
24
-
-
77953523681
-
Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites
-
Kobori H, Hashiguchi M, Piao J, Kato M, Ritprajak P, et al. (2010) Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. Immunology 130: 363-373.
-
(2010)
Immunology
, vol.130
, pp. 363-373
-
-
Kobori, H.1
Hashiguchi, M.2
Piao, J.3
Kato, M.4
Ritprajak, P.5
-
25
-
-
78650824229
-
Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma
-
Korpi JT, Hagstrom J, Lehtonen N, Parkkinen J, Sorsa T, et al. (2011) Expression of matrix metalloproteinases-2,-8,-13,-26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol 20: e18-22.
-
(2011)
Surg Oncol
, vol.20
-
-
Korpi, J.T.1
Hagstrom, J.2
Lehtonen, N.3
Parkkinen, J.4
Sorsa, T.5
-
27
-
-
0043123303
-
Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss
-
Ling V, Wu PW, Spaulding V, Kieleczawa J, Luxenberg D, et al. (2003) Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 82: 365-377.
-
(2003)
Genomics
, vol.82
, pp. 365-377
-
-
Ling, V.1
Wu, P.W.2
Spaulding, V.3
Kieleczawa, J.4
Luxenberg, D.5
-
28
-
-
0041381300
-
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
-
Suh WK, Gajewska BU, Okada H, Gronski MA, Bertram EM, et al. (2003) The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 4: 899-906.
-
(2003)
Nat Immunol
, vol.4
, pp. 899-906
-
-
Suh, W.K.1
Gajewska, B.U.2
Okada, H.3
Gronski, M.A.4
Bertram, E.M.5
-
29
-
-
34648823448
-
B7-H3 regulates the development of experimental allergic conjunctivitis in mice
-
Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, et al. (2007) B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 113: 52-57.
-
(2007)
Immunol Lett
, vol.113
, pp. 52-57
-
-
Fukushima, A.1
Sumi, T.2
Fukuda, K.3
Kumagai, N.4
Nishida, T.5
-
30
-
-
77953229339
-
Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
-
Sun J, Chen LJ, Zhang GB, Jiang JT, Zhu M, et al. (2010) Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 59: 1163-1171.
-
(2010)
Cancer Immunol Immunother
, vol.59
, pp. 1163-1171
-
-
Sun, J.1
Chen, L.J.2
Zhang, G.B.3
Jiang, J.T.4
Zhu, M.5
-
31
-
-
84870980029
-
B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence
-
Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, et al. (2012) B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunol Immunother 61: 2171-2182.
-
(2012)
Cancer Immunol Immunother
, vol.61
, pp. 2171-2182
-
-
Sun, T.W.1
Gao, Q.2
Qiu, S.J.3
Zhou, J.4
Wang, X.Y.5
-
32
-
-
63549150834
-
Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases
-
Chavin G, Sheinin Y, Crispen PL, Boorjian SA, Roth TJ, et al. (2009) Expression of immunosuppresive B7-H3 ligand by hormone-treated prostate cancer tumors and metastases. Clin Cancer Res 15: 2174-2180.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2174-2180
-
-
Chavin, G.1
Sheinin, Y.2
Crispen, P.L.3
Boorjian, S.A.4
Roth, T.J.5
-
33
-
-
79959864289
-
Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3
-
Schneider T, Hoffmann H, Dienemann H, Schnabel PA, Enk AH, et al. (2011) Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3. J Thorac Oncol 6: 1162-1168.
-
(2011)
J Thorac Oncol
, vol.6
, pp. 1162-1168
-
-
Schneider, T.1
Hoffmann, H.2
Dienemann, H.3
Schnabel, P.A.4
Enk, A.H.5
-
34
-
-
4344674058
-
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis
-
Castriconi R, Dondero A, Augugliaro R, Cantoni C, Carnemolla B, et al. (2004) Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis. Proc Natl Acad Sci U S A 101: 12640-12645.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 12640-12645
-
-
Castriconi, R.1
Dondero, A.2
Augugliaro, R.3
Cantoni, C.4
Carnemolla, B.5
-
35
-
-
70349852616
-
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression
-
Ahmed N, Salsman VS, Yvon E, Louis CU, Perlaky L, et al. (2009) Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression. Mol Ther 17: 1779-1787.
-
(2009)
Mol Ther
, vol.17
, pp. 1779-1787
-
-
Ahmed, N.1
Salsman, V.S.2
Yvon, E.3
Louis, C.U.4
Perlaky, L.5
-
36
-
-
84871266778
-
Potential of human gammadelta T cells for immunotherapy of osteosarcoma
-
Li Z, (2013) Potential of human gammadelta T cells for immunotherapy of osteosarcoma. Mol Biol Rep 40: 427-437.
-
(2013)
Mol Biol Rep
, vol.40
, pp. 427-437
-
-
Li, Z.1
-
37
-
-
77957904791
-
Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma
-
Biller BJ, Guth A, Burton JH, Dow SW, (2010) Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med 24: 1118-1123.
-
(2010)
J Vet Intern Med
, vol.24
, pp. 1118-1123
-
-
Biller, B.J.1
Guth, A.2
Burton, J.H.3
Dow, S.W.4
-
38
-
-
33644689145
-
Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis
-
Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, et al. (2006) Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 12: 457-459.
-
(2006)
World J Gastroenterol
, vol.12
, pp. 457-459
-
-
Wu, C.P.1
Jiang, J.T.2
Tan, M.3
Zhu, Y.B.4
Ji, M.5
-
39
-
-
70449534753
-
Clinical importance of B7-H3 expression in human pancreatic cancer
-
Yamato I, Sho M, Nomi T, Akahori T, Shimada K, et al. (2009) Clinical importance of B7-H3 expression in human pancreatic cancer. Br J Cancer 101: 1709-1716.
-
(2009)
Br J Cancer
, vol.101
, pp. 1709-1716
-
-
Yamato, I.1
Sho, M.2
Nomi, T.3
Akahori, T.4
Shimada, K.5
-
40
-
-
14944376718
-
Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts
-
Pautke C, Schieker M, Tischer T, Kolk A, Neth P, et al. (2004) Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 24: 3743-3748.
-
(2004)
Anticancer Res
, vol.24
, pp. 3743-3748
-
-
Pautke, C.1
Schieker, M.2
Tischer, T.3
Kolk, A.4
Neth, P.5
-
41
-
-
57649217290
-
Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion
-
Fromigue O, Hamidouche Z, Marie PJ, (2008) Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 283: 30549-30556.
-
(2008)
J Biol Chem
, vol.283
, pp. 30549-30556
-
-
Fromigue, O.1
Hamidouche, Z.2
Marie, P.J.3
|